Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...

Eli Lilly is escalating its legal push to protect the exclusivity of its high-profile weight-loss and diabetes drugs, Zepbound and Mounjaro, by suing two compounding pharmacies — Strive Pharmacy and ...

Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

Hundreds of thousands of people across the country are taking Semaglutide or Tirzepatide. Many of those people get their medication through a compounding pharmacy as opposed to getting the brand ...

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.

Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...

If you are a state-licensed pharmacy or physician compounding under 503A or an outsourcing facility under 503B, you can no longer compound tirzepatide as the enforcement discretion period has ended.

Those are barred for tirzepatide starting Wednesday and May 22 for semaglutide. But a neighborhood compounding pharmacy, for example, will still be able to make variations of the name-brand drugs.

The Therapeutic Goods Administration (TGA) has accepted a court-enforceable undertaking from Your Solution Compounding ...

The National Association of Boards of Pharmacy (NABP), which helps ... For those who still choose to use a compounded version of tirzepatide or semaglutide, So recommends the following: Some ...

Australia’s Therapeutic Goods Administration (TGA) has accepted a court-enforceable undertaking from Your Solution ...